FDA offers clues to AI regulation with RecovryAI designation

FDA offers clues to AI regulation with RecovryAI designation

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can reach Katie on Signal at palmer.01. The Food and Drug Administration has been talking a big game about bringing artificial intelligence to patients. In January,…